Biomerica (BMRA) Assets Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -18.24% |
| Nov 30, 2025 | -16.06% |
| Aug 31, 2025 | -15.48% |
| May 31, 2025 | -19.20% |
| Feb 28, 2025 | -2.13% |
| Nov 30, 2024 | 0.66% |
| Aug 31, 2024 | 3.20% |
| May 31, 2024 | 12.02% |
| Feb 29, 2024 | 15.33% |
| Nov 30, 2023 | 16.86% |
| Aug 31, 2023 | 22.08% |
| May 31, 2023 | 22.58% |
| Aug 31, 2022 | 17.60% |
| May 31, 2022 | 17.78% |
| Feb 28, 2022 | 26.24% |
| Nov 30, 2021 | 21.53% |
| Aug 31, 2021 | 15.47% |
| May 31, 2021 | 15.59% |
| Feb 28, 2021 | 17.83% |
| Nov 30, 2020 | 19.50% |
| Aug 31, 2020 | 21.21% |
| May 31, 2020 | 23.03% |
| Feb 29, 2020 | 7.09% |
| Nov 30, 2019 | 3.49% |
| Aug 31, 2019 | 2.14% |
| May 31, 2019 | -4.11% |
| Feb 28, 2019 | -4.17% |
| Nov 30, 2018 | -1.41% |
| Aug 31, 2018 | -4.71% |
| May 31, 2018 | -3.97% |
| Aug 31, 2017 | -3.85% |
| May 31, 2017 | -2.07% |
| Feb 28, 2017 | -0.24% |
| Nov 30, 2016 | 1.94% |
| Aug 31, 2016 | 2.45% |
| May 31, 2016 | 2.93% |